Recurrent chromosomal abnormalities in human embryonic stem cells.
about
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsChanging Paradigms in Cranio-Facial Regeneration: Current and New Strategies for the Activation of Endogenous Stem CellsStem cell application for osteoarthritis in the knee joint: A minireviewAneuploidy in pluripotent stem cells and implications for cancerous transformationStandardization of the teratoma assay for analysis of pluripotency of human ES cells and biosafety of their differentiated progenyThe landscape of somatic copy-number alteration across human cancers.Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics.Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogelsChromosome 7 and 19 trisomy in cultured human neural progenitor cells.Pluripotency genes overexpressed in primate embryonic stem cells are localized on homologues of human chromosomes 16, 17, 19, and XCell-autonomous correction of ring chromosomes in human induced pluripotent stem cellsNormal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidyQuality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation.LPA-primed astrocytes induce axonal outgrowth of cortical progenitors by activating PKA signaling pathways and modulating extracellular matrix proteinsMutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterpartsLessons from human teratomas to guide development of safe stem cell therapies.Genetic and epigenetic instability in human pluripotent stem cells.Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cellsPluripotency and its layers of complexity.Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitationsDerivation of two new human embryonic stem cell lines from nonviable human embryos.The essential role of evasion from cell death in cancer.Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges.Human mesenchymal stem cells possess different biological characteristics but do not change their therapeutic potential when cultured in serum free mediumGenomic instability of human embryonic stem cell lines using different passaging culture methods.Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.Human pluripotent stem cells: applications and challenges in neurological diseases.Human embryonic stem cell responses to ionizing radiation exposures: current state of knowledge and future challengesScreening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.Non-colony type monolayer culture of human embryonic stem cells.Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q.High-throughput karyotyping of human pluripotent stem cells.Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cellsHigher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability.Aneuploid cells are differentially susceptible to caspase-mediated death during embryonic cerebral cortical development.Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells.Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidyCurrent protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations.
P2860
Q24634829-E6184F38-E0A8-44FE-BE93-DBAEF30A588CQ26768579-7381BA5B-4954-49D6-92E4-B77909F6303FQ26827246-E7D75DC1-19B2-4B5C-8016-2F78837C7657Q27013982-6C2C4ACC-0FD7-4089-8F0E-E99C4CFAC15FQ27317676-3DE5EEF0-F06A-4ECC-89C3-A472D3E3B137Q29547648-38889490-15EC-45C7-888A-9F81494A0552Q30391597-892DDA91-BE45-4C7C-BB99-189F00851607Q30541092-FC83F412-5EF5-47D1-A2BD-6911227CB514Q33515583-01047D65-BF74-4943-A422-7548D51F8274Q33636608-3045A700-8445-47B9-880F-477CEF19B9F1Q33648633-629BC4AF-D871-4615-9F23-E1996E218D42Q33999117-BD354471-7095-4594-80E1-B2CDC43E31F2Q34038185-CABA1F72-B167-4A6C-93CB-9594A86CF7F4Q34242029-CFC7FE81-5234-49EF-9ED5-FBD190A2B826Q34294018-82A0ABD5-BB36-4CD4-B41B-6D60F5041B34Q34298868-2E14B377-D368-4F0E-BB87-37078C6112AFQ34316491-8A2CCDEA-B113-45E3-B34F-D34B588AADECQ34333314-E45F1087-20DB-41A9-85D1-324670ED8699Q34503625-99BDAC1C-EB1C-425D-ABD7-C4AA83A1ECB4Q34596358-4BD84711-B137-4245-B56D-DEA79F4A0391Q34800989-147953BF-11DF-4908-9E63-C469B15D73BCQ35054489-91A5638E-D397-4443-8F8D-F7190532D693Q35083049-864A08C3-2CA0-4114-BB71-8AA001B3D8C0Q35648168-AC7FF9B7-696B-438D-BF31-093DB280F9BDQ35653080-BA6A622D-A3BF-4F25-AD7B-B0F4CBC81264Q35686581-CBD37500-18AF-4371-88BF-20228C8ADA29Q35966957-F7068D03-0B73-420E-86EB-BBB8C11923E6Q36193696-855032E4-D867-4AE9-8779-655676765818Q36200201-CBE5B4C4-4C30-4F55-971A-3E3B607783E5Q36266493-8B3DCFA2-B486-40A6-B3B8-02148E36C5D9Q36321047-F353F298-5CBC-4C24-80EC-B516EA517B9CQ36374337-EC2F00AA-49D6-4046-B48E-81593DFC52EEQ36403953-A7D73D6E-D4FB-4C39-B697-FD6A7EF1063CQ36413729-1D855833-DFB9-4733-BF80-A540598E3783Q36673714-9F068B5C-8D18-404C-93B6-E9700291F93EQ36678840-18FB7B3E-C5B0-4BD4-8838-88B493805CEAQ36734923-7E853274-C799-4E0D-9623-4F9EC374BE32Q36934047-0E9A1EA5-E0D0-4762-8A55-0105204D31EEQ36985112-612BA555-B497-4AAB-8CA9-BF745C2B480AQ37194068-39FCF887-5200-4011-B276-67614ED93C1E
P2860
Recurrent chromosomal abnormalities in human embryonic stem cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Recurrent chromosomal abnormalities in human embryonic stem cells.
@en
Recurrent chromosomal abnormalities in human embryonic stem cells.
@nl
type
label
Recurrent chromosomal abnormalities in human embryonic stem cells.
@en
Recurrent chromosomal abnormalities in human embryonic stem cells.
@nl
prefLabel
Recurrent chromosomal abnormalities in human embryonic stem cells.
@en
Recurrent chromosomal abnormalities in human embryonic stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Recurrent chromosomal abnormalities in human embryonic stem cells.
@en
P2093
Afroditi Mertzanidou
Catherine Staessen
Claudia Spits
Ileana Mateizel
Inge Liebaers
Josiane Van der Elst
Karen Sermon
Mieke Geens
Yves Vandeskelde
P2860
P2888
P304
P356
10.1038/NBT.1510
P577
2008-11-23T00:00:00Z